Information Provided By: 
Fly News Breaks for December 11, 2019
ACHC
Dec 11, 2019 | 06:03 EDT
Wells Fargo analyst Peter Costa downgraded Acadia Healthcare to Market Perform from Outperform with a price target of $35, down from $37. The analyst says the shares have moved closer to his price target and sees less than 10% upside. Wells Fargo's new rating parameters focus on relative performance compared to the group, while previously it focused on comparison to the market as a whole, Costa tells investors in a research note. This resulted in him downgrading five names in the Pharmacy/Ancillary Benefits space.
News For ACHC From the Last 2 Days
